Brazil court strips Gilead hepatitis drug patent, politician says

FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam/File Photo

BRASILIA/SAO PAULO (Reuters) – A Brazilian court has stripped the patent protection of a Gilead Sciences Inc big-selling hepatitis C treatment in Brazil, paving the way for cheaper generics, a presidential candidate who pushed for the move said on Monday. At a campaign event in the northeastern city of Maceio, center-left candidate Marina Silva said […]

Continue reading this article with a Fiji Times online membership.

More Stories